LYRA - Multiplikator forward rega marang pendapatan Lyra Therapeutics

Logo korporat perusahaan Lyra Therapeutics Inc (LYRA)

Against the backdrop of risks regarding final test failures and dependence on a single platform, the daily chart on GURU.Markets reflects the forward P/S dynamics of Lyra Therapeutics, Inc. (LYRA), where the 1.40 metric determines the parameter status. While its reputation as an ENT innovator strengthens physician confidence, the current portfolio rebalancing following sinusitis setbacks is forcing the business to optimize expenses and seek new niches.

LYRA lyratherapeutics.com: Rega forward marang dodolan ing interval 04.07.2022 - 28.03.2026

Rincian metrik komprehensif lan analitis Lyra Therapeutics (LYRA)

Analisis umum perusahaan:Lyra Therapeutics, Inc LYRA
Produk sing diprodhuksi lyratherapeutics.com

The forward P/S reflects the market value of the business relative to its expected sales, allowing for an assessment of the premium paid for potential growth. By analyzing the projected P/S of Lyra Therapeutics, Inc. (LYRA), an investor compares the current market capitalization with the estimated revenue from the commercialization of LYR-210 systems, which is critical for the biotech sector where company valuation is based on future success in treating chronic rhinosinusitis.

Pesaing wigati

Multiplikator Forward P/S HLN (Haleon PLC)|Multiplikator Forward P/S Kenvue Corp KVUE|Verona Pharma PLC - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep jyongbio.com|LGND: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan AMRX|Rasio rega marang prakiraan pendapatan Perrigo Company|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Alvotech ALVO|Multiplikator Forward P/S LQDA|GLPG: Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S ANIP (ANI Pharmaceuticals, Inc.)|Rasio kapitalisasi marang dodolan sing dikarepake MannKind Corp (MNKD)|AMPH: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan PCRX (Pacira)|ARS Pharmaceuticals (SPRY) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan TBPH|AQST (Aquestive Corp) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan scPharmaceuticals Inc. (SCPH)|Multiplikator forward rega marang pendapatan TECX (Tectonic Therapeutic, Inc.)|TNXP (Tonix Pharmaceuticals Holding) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan SXT Pharmaceuticals SXTC|Rega forward marang dodolan EPRX|BHST - Rasio rega marang prakiraan pendapatan|eXoZymes (EXOZ) - Multiplikator forward rega marang pendapatan|ORMP: Multiplikator Forward P/S|ENTX: Rasio rega marang pendapatan sing dikarepake|HYFT (ipatherapeutics.com) - Multiplikator Forward P/S|Multiplikator Forward P/S ABVC BioPharma|Rasio rega marang prakiraan pendapatan Cumberland Pharmaceuticals Inc. (CPIX)|QNTM (Quantum BioPharma Ltd.) - Rega forward marang dodolan|Multiplikator Forward P/S FGEN (fibrogen.com)|Telomir Pharmaceuticals (TELO) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|RANI - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Synergy CHC SNYR|RLYB: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Lexaria (LEXX)|Rasio rega marang prakiraan pendapatan Pulmatrix|Kapitalisasi marang prakiraan pendapatan PTHL (ftzy.com.cn)|Multiplikator Forward P/S APM|Multiplikator forward rega marang pendapatan Impact BioMedical Inc IBO|Rasio rega marang prakiraan pendapatan tnfpharma.com TNFA|Rega forward marang dodolan YCBD|PainReform Ltd - Multiplikator Forward P/S|Altamira Therapeutics Ltd (CYTO) - Multiplikator forward rega marang pendapatan|lipella.com (LIPO) - Rasio rega marang prakiraan pendapatan|OptiNose (OPTN) - Multiplikator Forward P/S|PIRS (Pieris Pharmaceuticals Inc) - Multiplikator Forward P/S|PROC: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Petros Pharmaceuticals, Inc. (PTPI)|Multiplikator Forward P/S Qilian International Corp (QLI)|ACELYRIN, Inc. - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S tffpharma.com TFFP